JPRN-UMIN000010051已完成未知
Combined efficacy of DPP-4 inhibitor in type 2 diabetic patients in the medical treatment of Sulfonylurea - Combined efficacy of DPP-4 inhibitor in type 2 diabetic patients in the medical treatment of Sulfonylurea
Osaka Saiseikai Noe Hospital0 个研究点目标入组 120 人开始时间: 2013年2月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
The 55th Annual Meeting of the Japan Diabetes Society The 56th Annual Meeting of the Japan Diabetes Society
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with type 1 diabetes Patients with a history of severe ketosis, diabetic coma or pre-coma within the past six months Patients with severe infection, before and after surgery, or severe trauma Patients with moderate renal impairment or more(serum creatinine level:1.5mg/dl or more(male),1.3mg/dl or more(female)) Patients in the insulin therapy, rapid insulin secretagogue, or alpha-glucosidase inhibitor Patients with a planned pregnancy or likely to be pregnant or lactating patients, or pregnant patients Patients with a history of hypersensitivity to study drug
研究者
相似试验
已完成
4 期
Effects of DPP4 Inhibitor Versus SGLT2 InhibitorIschemic Heart DiseaseDiabetes Mellitus, Type 2NCT03178591Chiang Mai University43
招募中
不适用
Efficacy and safety of DPP-4 inhibitors in diabetic patients undergoing hemodialysisJPRN-UMIN000018445Keiai Hospital60
已完成
3 期
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DType 2 DiabetesNCT01937598Michael A. Nauck16
进行中（未招募）
不适用
ANTIDIABETIC EFFECTS OF ADDING A DPP-4 INHIBITOR (SITAGLIPTIN) TO PRE-EXISTING TREATMENT WITH AN INCRETIN MIMETIC (LIRAGLUTIDE) IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH METFORMITYPE 2 DIABETESMedDRA version: 16.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-001764-35-DEDiabeteszentrum Bad Lauterberg
已完成
4 期
DPP4 Inhibitor on Glycemic VariabilityDiabetes Mellitus, Type 2NCT04654676University Malaysia Sarawak12